About this event

  • Date and time Mon 25 Nov 2019 from 8:00am to 6:00pm
  • Location Royal Society of Medicine
  • Organised by Oncology

Join us for the 4th year of this important conference, where international leaders in the field will discuss the importance of effective cancer control in low and middle-income countries (LMIC) and highlight the magnitude of the disparities and issues that currently exist. 

This event is part of the inaugural London Global Cancer Week - a series of coordinated international discussions and events that provides a comprehensive image of the growing incidence of cancer worldwide, encourages countries to prioritise cancer control services in their health strategies, and discusses how the UK can contribute towards building capacity for sustainable cancer control in developing countries through training, research, aid, and diplomacy.

At the RSM meeting, first-hand accounts of healthcare professionals working in low and middle income countries will share experiences to increase awareness on global cancer collaborations that currently exist, improve understanding of the challenges to delivering cancer care, and provide a forum to discuss future strategies to improve global cancer control. 

Topics include:

- Build collaborative networks between LMIC, UK and globally
- Address the global disparity in cancer care through collaborative networks
- Promote learning and sharing through practice and data-sharing across the globe
- Advocate for improvement in global cancer control and learn how to become further involved in this field
- Create a global grassroots network for cancer control in LMIC
- Provide an opportunity for attendees to showcase their work in this field

Key international healthcare organisations including THET and Kings Health Partners will be represented. 

Call for abstracts: Vanessa Moss annual prize

Prize: Winner of best abstract - £250 and invited for oral presentation; Top 10 abstracts – poster presentation

Submission deadline: 1st August 2019

Eligibility Criteria:

1. Any scientist or healthcare professional working in the field of global cancer control may apply

2. Collaborative research / service delivery in which the applicant has been significantly involved, in global cancer control, focusing on LMICs (as defined by world bank group)

3. The project may be clinical or scientific

4. Work may have been published previously (but not before 2018)

Abstract guidelines:

400 words maximum, including background, methods, results and discussion.

Submissions open to HICs and LMICs. The judging panel will include oncologists and experts in the field of global cancer care who will consider the originality and the impact of the research on the quality of care for patients with cancer in LMICs, within the context of the resources available to the host institution.

The winner must agree to attend the conference.

For further information and to submit, please contact oncology@rsm.ac.uk

Tickets

Early Bird pricing available until 15 September 2019.

Member

RSM Fellow RSM Associate RSM Retired Fellow RSM Trainee RSM Student
£55.00 £45.00 £45.00 £45.00 £25.00

Non - Member

Consultant / GP AHP / Nurse / Midwife Trainee Student
£92.00 £75.00 £75.00 £42.00

Key speakers

Dr Ophira Ginsburg

Professor Ophira Ginsburg

Director Perlmutter Cancer Center High Risk Program, New York University, New York, US

Speaker's biography

Professor Ginsburg is a medical oncologist and global women’s health researcher with technical and policy expertise in noncommunicable diseases prevention and management.  She is the director of the high-risk cancer genetics program and associate professor in the section for global health, department of population health at New York University School of Medicine. Formerly based at the University of Toronto, from 2015 to 2016 she was a medical officer at WHO and continues to serve as a consultant to several UN agencies, providing technical assistance to member states on national cancer control planning and policies.

Over the last 15 years, Prof Ginsburg developed an inter-disciplinary collaborative program of research, education, and policy guidance in cancer control, with colleagues on five continents. The overarching aim of her work is to improve equitable access to early detection for breast and cervical cancer in low-income and middle-income countries. She also conducts public health research to reduce cancer disparities for women in underserved communities in North America, and is leading a new study funded by the U.S. National Institutes of Health (“Cancer Moonshot” program), to improve access to cancer genetics services through primary care clinics in the New York area.

Dr Gilberto Lopes

Dr Gilberto Lopes

Associate Professor of Clinical Medicine, Sylvester Comprehensive Cancer Center and Editor in Chief, Journal of Global Oncology, American Society of Clinical Oncology

Speaker's biography

Dr. Gilberto Lopes is an expert in medical oncology in low- and middle-income countries, is medical director for International programs and associate director for global oncology at the Sylvester Comprehensive Cancer Center and associate professor at the University of Miami Miller School of Medicine. He is also an associate editor for ASCO University and for ASCO’s Journal of Global Oncology. From 2006 to 2013, Dr. Lopes worked for the Johns Hopkins University Singapore International Medical Center, and, prior to that, was the chief medical and scientific officer for the Oncoclinicas Group, the largest oncology provider in Latin America with 35 clinics and more than 300 oncologists in nine states in Brazil.

Dr. Lopes has published widely, with more than 100 papers in journals such as the Journal of Clinical Oncology, Cancer, The Lancet, The Lancet Oncology, and Nature Reviews, and has lectured nationally and internationally. He has been principal or co-principal investigator or steering committee member in more than 100 studies and clinical trials covering breast, gastrointestinal, genitourinary, and thoracic cancers. His areas of research interest extend to health economics, value, policy, and access to cancer drugs and treatment in low- and middle-income countries. He has served as an expert for the International Atomic Energy Agency, the World Health Organization and the Pan-American Health Organization.

After graduating from medical school in Brazil, Dr. Lopes received residency training in internal medicine and completed a fellowship in hematology/oncology at the University of Miami.

Professor Richard Sullivan

Professor Richard Sullivan

King's Health Partners, UK;
Director, Institute of Cancer Policy, Co-Director Conflict & Health Research Group, King's College London

Speaker's biography

Professor Richard Sullivan's research group studies health systems, particular NCD policy and the impact of conflict on health. He is Professor of Cancer and Global Health at King’s College London, and Director of the Institute of Cancer Policy (ICP) and co-Director of the Conflict and Health Research Group.  As well as holding a number of Visiting Chairs, Richard is an NCD advisor to the WHO, civil-military advisor to Save the Children, and a member of the National Cancer Grid of India His research focuses on global cancer policy and planning, and health systems strengthening, particularly conflict ecosystems. He is principle investigator on research programs ranging from automated radiotherapy planning for low resource settings to use of augmented/virtual reality for cancer surgery, through to political economy to build affordable, equitable cancer control plans. Richard has led five Lancet Oncology Commissions and worked on four others. He is currently co-leading Lancet Oncology commissions on the Future of Cancer Research in Europe and Cancer Care in Conflict. In conflict systems, his research teams have major programs in capacity building in conflict medicine across the Middle East and North Africa (r4hc-mena.org), as well as studies of the basic package of health services in Afghanistan, civil-military co-operation in health security, polio eradication and insecurity in Pakistan, and use of intelligence in high security disease outbreaks.  Professor Sullivan qualified in medicine and trained in surgery (urology), gaining his PhD from University College London. He was also clinical director of Cancer Research UK between 1999 and 2008. Following a period at the London School of Economics working on complex healthcare systems he moved to King’s College London in 2011. 

Agenda

View the programme

Registration, tea and coffee
Welcome and introduction

Dr Susannah Stanway, Consultant Medical Oncologist, Royal Marsden NHS Foundation Trust

Session One

Chair: Professor David Collingridge, Editor-in-Chief, The Lancet Oncology and Professor Diana Sarfati, Head of Department, Department of Public Health, University of Otago

The promise of Universal Health Coverage (UHC) for global cancer: moving from challenges to solutions

Professor Richard Sullivan, Professor of Cancer and Global Health, King’s College London

The challenge of falsified medicines

Ms Chloe Tuck, International Projects Lead, Commonwealth Pharmacists Association and Ms Oksana Pyzik, Board Trustee, Commonwealth Pharmacists Association

Digital health in LMICs

Professor Shafi Ahmed, Surgeon, St Bartholomew hospital and the Royal London hospital

Why an understanding of anthropology is so important for cancer control

Dr Carlo Caduff, Doctor, King's Health Partners

Tea and coffee break

Poster viewing

The Vanessa Moss Prize

Vanessa Moss prize winner’s presentation

Presentation by winner

Creating a national advocacy movement

Ms Beatrice Wiafe Addai, Consultant Surgeon, Peace and Love Hospital, Accra, Ghana

The importance of engaging with decision makers

Professor Diana Sarfati

Oncology collaborations within the THET project portfolio

Mr Ben Simms, Chief Executive Officer, THET, London

Lunch

Poster viewing

Workshops

Africa

Dr Nazima Dharsee, Clinical Oncologist Ocean Road Cancer Institute, Dar es Salaam, Tanzania, Ms Beatrice Wiafe Addai, Professor Groesbeck Parham, Obstetrics and Gynaecology, University of North Carolina at Chapel Hill, USA and Dr Ajay Aggarwal Consultant Clinical Oncologist, Guy's Cancer - Guy's and St Thomas' NHS Foundation Trust and Dr Warren Phipps, Medical Director, Uganda Cancer Institute and Fred Hutchinson Centre Cancer Alliance, USA

 

Asia

Dr C.S. Pramesh, Director, Tata Memorial Hospital, Mumbai, India, Dr Bhawna Sirohi, Director, Medical Oncology, Max Institute of Cancer Care, New Delhi, Professor Shailesh Shrikhande, Professor of Surgery, Tata Memorial Center, Mumbai, India and Professor Anil D’Cruz, Professor and Chief of the Department of Head and Neck Surgery, Tata Memorial Hospital, Mumbai, India

Session Two

Chairs: Professor Ophira Ginsburg, Professor of Medical Oncology, New York University, USA and Professor Anil D’Cruz

Development of resource stratified oncology guidelines

Professor Ben Anderson, Professor of Surgery, University of Washington, Department of Global Health, USA

Setting up a global oncology programme

Dr Gilberto Lopes, Medical Oncologist, Sylvester Cancer Center, Miami, USA

The role of primary care in global oncology

Professor Ophira Ginsburg

Tea and coffee break

Poster viewing

Challenges and opportunities in developing a cancer center in an LMIC

Professor Shailesh Shrikhande

Understanding breast cancer survivorship in Tanzania

Dr Nazima Dharsee

Closing remarks
Close of meeting

Drinks reception

Location

Royal Society of Medicine, 1 Wimpole Street, London, W1G 0AE, United Kingdom